GW&K Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191K Buy
803
+213
+36% +$44.3K ﹤0.01% 410
2026
Q1
$125K Buy
590
+307
+108% +$66.1K ﹤0.01% 429
2025
Q4
$58K Buy
283
+3
+1% +$565 ﹤0.01% 522
2025
Q3
$44K Hold
280
– – ﹤0.01% 552
2025
Q2
$47K Buy
280
+9
+3% +$1.34K ﹤0.01% 523
2025
Q1
$37K Buy
271
+144
+113% +$18.4K ﹤0.01% 530
2024
Q4
$15K Buy
127
+2
+2% +$233 ﹤0.01% 677
2024
Q3
$14K Buy
125
+10
+9% +$1.05K ﹤0.01% 676
2024
Q2
$11K Buy
115
+15
+15% +$1.53K ﹤0.01% 701
2024
Q1
$11K Buy
100
+1
+1% +$108 ﹤0.01% 666
2023
Q4
$10K Sell
99
-6
-6% -$595 ﹤0.01% 667
2023
Q3
$9K Hold
105
– – ﹤0.01% 624
2023
Q2
$10K Buy
+105
New +$8.87K ﹤0.01% 600
2022
Q3
– Sell
-10
Closed -$1K – 461
2022
Q2
$1K Buy
+10
New +$568 ﹤0.01% 797

Other funds holding CAH

GW&K Investment Management's CAH Position: Q2 2026 in Review

GW&K Investment Management increased its Cardinal Health (CAH) stake by 36% in Q2 2026, buying an estimated $44.3K and bringing the position to 803 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

GW&K Investment Management first reported a position in CAH in Q2 2022 and has held it in 14 quarters since. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GW&K Investment Management held 803 shares of Cardinal Health worth $191K as of Q2 2026.
  • GW&K Investment Management bought 213 Cardinal Health shares in Q2 2026, an estimated $44.3K.
  • Cardinal Health made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #410 holding.
  • GW&K Investment Management first reported a position in Cardinal Health in Q2 2022 and has held it in 14 quarters since.
  • 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.